Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Yuyu Zhang, Yi Zhang, Shiyi Yao, Liping Chen, Qin Dong, Ranwen Luo, Kaiyue Zheng, Jing Liu, Yiming Liu, Yutong Chen, Yuxin He, Zhejie Chen, Ling Li
Formato: Artículo Open Access
Publicado: Wiley 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867019480143495168
author Yuyu Zhang
Yi Zhang
Shiyi Yao
Liping Chen
Qin Dong
Ranwen Luo
Kaiyue Zheng
Jing Liu
Yiming Liu
Yutong Chen
Yuxin He
Zhejie Chen
Ling Li
author_facet Yuyu Zhang
Yi Zhang
Shiyi Yao
Liping Chen
Qin Dong
Ranwen Luo
Kaiyue Zheng
Jing Liu
Yiming Liu
Yutong Chen
Yuxin He
Zhejie Chen
Ling Li
Yuyu Zhang
Yi Zhang
Shiyi Yao
Liping Chen
Qin Dong
Ranwen Luo
Kaiyue Zheng
Jing Liu
Yiming Liu
Yutong Chen
Yuxin He
Zhejie Chen
Ling Li
collection Wiley Open Access
contents Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives Yuyu Zhang Yi Zhang Shiyi Yao Liping Chen Qin Dong Ranwen Luo Kaiyue Zheng Jing Liu Yiming Liu Yutong Chen Yuxin He Zhejie Chen Ling Li Phytotherapy Research ABSTRACT Colorectal cancer (CRC), one of the most prevalent malignant neoplasms, ranks as a leading cause of cancer‐related mortality on a global scale. A particularly aggressive variant of CRC is colitis‐associated colon cancer (CAC). Patients with chronic inflammatory bowel disease (IBD) are at increased risk for CAC. The pathogenesis of CAC is influenced by numerous factors and is highly complex. Due to the complexity of the mechanism by which chronic inflammation of the intestine leads to the transformation of colorectal cancer, there is currently no standardized strategy for the advance prophylaxis of CAC. Significantly, phyto‐derivatives exhibit significant potential in the prevention of CAC. Currently, researches have demonstrated that natural products extracted from plants including polyphenols, alkaloids, saponins, terpenoids, polysaccharides, and plant extracellular vesicles can achieve significant anti‐inflammatory, antioxidant, and gut microbiota regulating activities through oral administration. It is a valuable opportunity for the application of natural products in chronic intestinal inflammation to inhibit the transformation of intestinal inflammation into malignancy. In this review, we provide a comprehensive analysis of the predisposing factors and pathogenesis of CAC, along with the mechanisms through which various plant‐derived compounds inhibit CAC development. This work aims to provide innovative and practical treatment strategies for the prevention of CAC. 10.1002/ptr.70015 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.70015
format Artículo Open Access
id wiley_oa_10_1002_ptr_70015
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives
Yuyu Zhang
Yi Zhang
Shiyi Yao
Liping Chen
Qin Dong
Ranwen Luo
Kaiyue Zheng
Jing Liu
Yiming Liu
Yutong Chen
Yuxin He
Zhejie Chen
Ling Li
Phytotherapy Research
Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives Yuyu Zhang Yi Zhang Shiyi Yao Liping Chen Qin Dong Ranwen Luo Kaiyue Zheng Jing Liu Yiming Liu Yutong Chen Yuxin He Zhejie Chen Ling Li Phytotherapy Research ABSTRACT Colorectal cancer (CRC), one of the most prevalent malignant neoplasms, ranks as a leading cause of cancer‐related mortality on a global scale. A particularly aggressive variant of CRC is colitis‐associated colon cancer (CAC). Patients with chronic inflammatory bowel disease (IBD) are at increased risk for CAC. The pathogenesis of CAC is influenced by numerous factors and is highly complex. Due to the complexity of the mechanism by which chronic inflammation of the intestine leads to the transformation of colorectal cancer, there is currently no standardized strategy for the advance prophylaxis of CAC. Significantly, phyto‐derivatives exhibit significant potential in the prevention of CAC. Currently, researches have demonstrated that natural products extracted from plants including polyphenols, alkaloids, saponins, terpenoids, polysaccharides, and plant extracellular vesicles can achieve significant anti‐inflammatory, antioxidant, and gut microbiota regulating activities through oral administration. It is a valuable opportunity for the application of natural products in chronic intestinal inflammation to inhibit the transformation of intestinal inflammation into malignancy. In this review, we provide a comprehensive analysis of the predisposing factors and pathogenesis of CAC, along with the mechanisms through which various plant‐derived compounds inhibit CAC development. This work aims to provide innovative and practical treatment strategies for the prevention of CAC. 10.1002/ptr.70015 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Inflammatory Bowel Disease Induces Colorectal Cancer: Risk Factors, Triggering Mechanisms, and Treatment With Phyto‐Derivatives
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.70015